Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03915184 |
Recruitment Status :
Active, not recruiting
First Posted : April 16, 2019
Last Update Posted : December 19, 2023
|
Sponsor:
CARsgen Therapeutics Co., Ltd.
Information provided by (Responsible Party):
CARsgen Therapeutics Co., Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | December 31, 2024 |
Estimated Study Completion Date : | December 31, 2034 |